Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph Weissleder

Showing results (711-720 of 807) with videos related to

Pageof 81
Sort By:
Plos One|December 17, 2008
BRAF activation initiates but does not maintain invasive prostate adenocarcinomaJoseph H Jeong, Zhenxiong Wang, Alexander S Guimaraes, et al.
Circulation Research|May 3, 2014
Differential contribution of monocytes to heart macrophages in steady-state and after myocardial infarctionTimo Heidt, Gabriel Courties, Partha Dutta, et al.
Cancer Research|December 7, 2013
Extracellular vesicles modulate the glioblastoma microenvironment via a tumor suppression signaling network directed by miR-1Agnieszka Bronisz, Yan Wang, Michal O Nowicki, et al.
Circulation Research|January 10, 2013
Polymeric nanoparticle PET/MR imaging allows macrophage detection in atherosclerotic plaquesMaulik D Majmudar, Jeongsoo Yoo, Edmund J Keliher, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 26, 2006
Cyclophosphamide increases transgene expression mediated by an oncolytic adenovirus in glioma-bearing mice monitored by bioluminescence imagingMartine L M Lamfers, Giulia Fulci, Davide Gianni, et al.
The Journal of Experimental Medicine|May 14, 2014
Pleural innate response activator B cells protect against pneumonia via a GM-CSF-IgM axisGeorg F Weber, Benjamin G Chousterman, Ingo Hilgendorf, et al.
Science (New York, N.Y.)|March 19, 2016
SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactionsFerdinando Pucci, Christopher Garris, Charles P Lai, et al.
Cancer Discovery|March 18, 2016
Reduced Proteolytic Shedding of Receptor Tyrosine Kinases Is a Post-Translational Mechanism of Kinase Inhibitor ResistanceMiles A Miller, Madeleine J Oudin, Ryan J Sullivan, et al.
Nature Medicine|June 23, 2014
Chronic variable stress activates hematopoietic stem cellsTimo Heidt, Hendrik B Sager, Gabriel Courties, et al.
Journal of Neuro-Oncology|August 10, 2012
CT322, a VEGFR-2 antagonist, demonstrates anti-glioma efficacy in orthotopic brain tumor model as a single agent or in combination with temozolomide and radiation therapyJ Dawn Waters, Carlos Sanchez, Ayguen Sahin, et al.
Pageof 81

Showing results (711-720 of 807) with videos related to

Sort By:
Pageof 81
Plos One|December 17, 2008
BRAF activation initiates but does not maintain invasive prostate adenocarcinomaJoseph H Jeong, Zhenxiong Wang, Alexander S Guimaraes, et al.
Circulation Research|May 3, 2014
Differential contribution of monocytes to heart macrophages in steady-state and after myocardial infarctionTimo Heidt, Gabriel Courties, Partha Dutta, et al.
Cancer Research|December 7, 2013
Extracellular vesicles modulate the glioblastoma microenvironment via a tumor suppression signaling network directed by miR-1Agnieszka Bronisz, Yan Wang, Michal O Nowicki, et al.
Circulation Research|January 10, 2013
Polymeric nanoparticle PET/MR imaging allows macrophage detection in atherosclerotic plaquesMaulik D Majmudar, Jeongsoo Yoo, Edmund J Keliher, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 26, 2006
Cyclophosphamide increases transgene expression mediated by an oncolytic adenovirus in glioma-bearing mice monitored by bioluminescence imagingMartine L M Lamfers, Giulia Fulci, Davide Gianni, et al.
The Journal of Experimental Medicine|May 14, 2014
Pleural innate response activator B cells protect against pneumonia via a GM-CSF-IgM axisGeorg F Weber, Benjamin G Chousterman, Ingo Hilgendorf, et al.
Science (New York, N.Y.)|March 19, 2016
SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactionsFerdinando Pucci, Christopher Garris, Charles P Lai, et al.
Cancer Discovery|March 18, 2016
Reduced Proteolytic Shedding of Receptor Tyrosine Kinases Is a Post-Translational Mechanism of Kinase Inhibitor ResistanceMiles A Miller, Madeleine J Oudin, Ryan J Sullivan, et al.
Nature Medicine|June 23, 2014
Chronic variable stress activates hematopoietic stem cellsTimo Heidt, Hendrik B Sager, Gabriel Courties, et al.
Journal of Neuro-Oncology|August 10, 2012
CT322, a VEGFR-2 antagonist, demonstrates anti-glioma efficacy in orthotopic brain tumor model as a single agent or in combination with temozolomide and radiation therapyJ Dawn Waters, Carlos Sanchez, Ayguen Sahin, et al.
Pageof 81